Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

11 clinical studies listed.

Filters:

Hair Thinning

Tundra lists 11 Hair Thinning clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07520019

Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen & Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning Hair

The Nutra Harmony "Biotin, Collagen \& Keratin Beauty Complex" is an oral food/dietary supplement specifically designed to Promote hair growth for people suffering from temporary thinning hair. The main goal of this clinical trial is to evaluate the efficacy of two different doses of the study supplement (with 5,000 mcg vs 10,000 mcg biotin). Product formula with 10,000 mcg biotin per serving was clinically tested and shows results in strengthening the hair and increasing hair thickness by promoting the growth of terminal hairs in subjects, ages 21-50 years of age, with self-perceived thinning hair associated with poor diet, stress, and hormonal influences when compared to using the placebo tablet.

Gender: All

Ages: 21 Years - 50 Years

Updated: 2026-04-09

1 state

Hair Thinning
ACTIVE NOT RECRUITING

NCT06999408

Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning

This clinical trial is testing a new approach to help improve hair thinning using a combination of cosmetic treatments. The purpose of the study is to learn whether applying exosomes to the scalp, along with microneedling and a precision cooling device called TargetCool™. This study aims to determine whether this combination approach offers synergistic benefits for individuals with hair thinning. Exosomes are tiny particles that come from stem cells and contain growth factors and other nutrients. They are being studied for their potential to help regenerate skin and hair. TargetCool™ is an FDA-cleared device that uses precision cooling to reduce inflammation and improve comfort. Microneedling is a common, minimally invasive procedure that uses small needles to stimulate the skin and help absorb topical products more effectively. The study will include healthy men (ages 18 to 70) and women (ages approximately 45 to 70) who are not of childbearing potential. A total of 9 to 15 participants will be randomly placed into one of three groups: Group 1: Exosomes with TargetCool™ Group 2: Microneedling followed by exosomes and TargetCool™ Group 3: Microneedling followed by exosomes only Participants will receive four treatments over 9 weeks. Each visit may include microneedling, TargetCool™ treatment, and exosome application depending on group assignment. A small tattoo will be placed on the scalp to help capture consistent photographs, and a special imaging system (Canfield HairMetrix®) will be used to measure hair changes. Participants will return for follow-up visits at 3 and 6 months after the final treatment. The results will help determine whether this combination of cosmetic treatments is safe and beneficial for people experiencing hair thinning.

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-03-09

1 state

Hair Diseases
Alopecia
Hair Thinning
ACTIVE NOT RECRUITING

NCT07271212

Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir

The study aims to evaluate the efficacy of the Premium Revitalizing Elixir on human scalp skin. A total of 60 healthy adults, aged 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning will be recruited and randomly assigned into five groups receiving different formulations. Participants will use the product once daily for 56 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured. A self-assessment and assessment by a hair specialist on hair and scalp condition will also be provided at the end of the study (Day 56).

Gender: All

Ages: 18 Years - 60 Years

Updated: 2025-12-09

Scalp Health
Hair Condition
Hair Loss
+4
ENROLLING BY INVITATION

NCT07221773

Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair

The goal of this study is to determine how safe and effective it is to improve hair growth using XVIE solution applied on the scalp of women with self-perceived thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. Participants who qualify will complete 5 to 6 visits after voluntary consent has been given. Participant's scalp will be numbed and the XVIE solution will be applied by microneedling. Photographs will be taken at each visit to measure changes in hair volume, thickness, and growth. Every participant will receive active treatment twice over the 4 month period.

Gender: FEMALE

Ages: 28 Years - 65 Years

Updated: 2025-11-06

2 states

Hair Thinning
ENROLLING BY INVITATION

NCT07224555

Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning Hair

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in women with self-perceived thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 5 visits after voluntary consent has been given. Participants will be given a 30-day supply of the gummies at each visit over a 4-month period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Gender: FEMALE

Ages: 18 Years - 65 Years

Updated: 2025-11-06

4 states

Hair Thinning
RECRUITING

NCT07041489

Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair

The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair. The main questions this trial aims to answer are: * to confirm using photograph analytics, how much hair growth has increased in a marked area when using active treatment versus inactive treatment, and * participants assessment and satisfaction with the hair growth using scaled assessments. Participants who qualify will be asked to complete 6 to 7 visits after voluntarily consent has been given. The study is divided into two parts. In Part A participants will be randomly given either active or inactive treatment to use over 3 months. After 3 months, all participants will enter Part B of the study and will be given active treatment to use over the final 6 months of the study.

Gender: FEMALE

Ages: 28 Years - 65 Years

Updated: 2025-06-27

2 states

Hair Thinning
RECRUITING

NCT06869252

Autologous Adipose Cells Therapy

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Gender: All

Ages: 21 Years - 80 Years

Updated: 2025-05-31

1 state

Hair Loss/Baldness
Wrinkle Appearance
Volume
+5
RECRUITING

NCT06603194

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

Gender: FEMALE

Ages: 35 Years - 55 Years

Updated: 2024-09-19

1 state

Skin Laxity
Hair Thinning
Nails
ACTIVE NOT RECRUITING

NCT06579742

A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin

This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair thinning and shedding. The trial will last for 24 weeks and includes the completion of questionnaires and photo submissions at specific time points.

Gender: All

Ages: 40 Years - Any

Updated: 2024-08-30

1 state

Hair Thinning
Hair Loss
ACTIVE NOT RECRUITING

NCT06146166

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

The purpose of this study is to assess how an oral herbal supplement influences hair density, shine, growth, and microbiome.

Gender: FEMALE

Ages: 25 Years - 65 Years

Updated: 2024-08-27

1 state

Hair Thinning
ACTIVE NOT RECRUITING

NCT06515496

A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.

This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experiencing self-perceived hair thinning.

Gender: FEMALE

Ages: 35 Years - Any

Updated: 2024-07-23

1 state

Hair Thinning
Hair Shedding